Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
posted on
Mar 26, 2020 03:39PM
I agree 100% Jupiter. So far it has only been big talk with no convincing data to back it up for both the effect of apabetalone to module ACE2 and to disrupt interactions between virus and BET protein and/or histones.
BDAZ